JP Morgan Chase
BOLD

JP Morgan Chase’s Boundless Bio BOLD Stock Holding History

JP Morgan Chase’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$183 Hold
169
– – ﹤0.01% 7262
2025
Q4 		$203 Buy
+169
New +$211 ﹤0.01% 7156
2025
Q3 		– Sell
-1,127
Closed -$1.14K – 7777
2025
Q2 		$1.14K Sell
1,127
-18,125
-94% -$24.1K ﹤0.01% 6609
2025
Q1 		$29.1K Sell
19,252
-59,643
-76% -$124K ﹤0.01% 6039
2024
Q4 		$229K Buy
78,895
+68,959
+694% +$201K ﹤0.01% 5421
2024
Q3 		$34.5K Buy
9,936
+7,247
+270% +$26.3K ﹤0.01% 6102
2024
Q2 		$10.4K Buy
+2,689
New +$25.7K ﹤0.01% 6256

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

JP Morgan Chase's BOLD Position: Q1 2026 in Review

JP Morgan Chase held its Boundless Bio (BOLD) position steady in Q1 2026 at 169 shares worth $183. The position accounts for ﹤0.01% of the portfolio, ranked #7262.

JP Morgan Chase first reported a position in BOLD in Q2 2024 and has held it in 7 quarters since. The position peaked at $229K in Q4 2024. 36 funds tracked by Wall St. Rank hold BOLD as of Q1 2026.

  • JP Morgan Chase held 169 shares of Boundless Bio worth $183 as of Q1 2026.
  • JP Morgan Chase left its Boundless Bio share count unchanged in Q1 2026.
  • Boundless Bio made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7262 holding.
  • JP Morgan Chase first reported a position in Boundless Bio in Q2 2024 and has held it in 7 quarters since.
  • JP Morgan Chase's Boundless Bio position peaked at $229K in Q4 2024.
  • 36 funds tracked by Wall St. Rank held Boundless Bio as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.